Suda takes full control of ArTiMist
SUD Wed, 26 Aug 2015, 11:05am AEST
SUDA LTD (ASX: SUD) (SUDA), a leader in oro mucosal drug delivery, is pleased to announce the acquisition of the 20% minority shareholding in SUDA’s subsidiary company, Malaria Research Company Pty Ltd (MRC), which was owned by UK based ProtoPharma Ltd (PPL) and its parent London Pharma Ltd (LPL).
Stephen Carter, CEO
CEO
Stephen Carter, CEO, CEO
Fri, 16 Oct 2015, 1:00pm AEDT
Stephen Carter, CEO, CEO
Wed, 26 Aug 2015, 11:05am AEST
Stephen Carter, CEO, CEO
Tue, 9 Jun 2015, 11:00am AEST